Abstract
It is becoming evident that several aminopeptidases belonging to the M1 family such as aminopeptidase A (APA), placental leucine aminopeptidase (P-LAP), and adipocyte-derived leucine aminopeptidase (A-LAP) play important roles in the regulation of blood pressure under both the physiological and pathological conditions. They share HEXXH(X)18E zinc-binding and GAMEN motifs essential for enzymatic activities. In this review, the current situation regarding the biochemical characteristics of these enzymes including enzymatic properties and modes of action is summarized.
Similar content being viewed by others
Abbreviations
- A-LAP:
-
Adipocyte-derived leucine aminopeptidase
- Ang:
-
Angiotensin
- APA:
-
Aminopeptidase A
- APN:
-
Aminopeptidase N
- BP:
-
Blood pressure
- GLUT:
-
Glucose transporter
- P-LAP:
-
Placental leucine aminopeptidase
- RAS:
-
Renin-angiotensin system
References
Reaux A, Fournie-Zaluski MC, Llorens-Cortes C (2001) Angiotensin III: a central regulator of vasopressin release and blood pressure. Trends Endocrinol Metab 12:157–162
Banegas I, Prieto I, Vives F, Alba F, de Gasparo M, Segarra AB, Hermoso F, Duran R, Ramirez M (2006) Brain aminopeptidases and hypertension. J Renin Angiotensin Aldosterone Syst 7:129–134
Ruiz-Ortega M, Esteban V, Egido J (2007) The regulation of the inflammatory response through nuclear factor-κB pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases. Trends Cardiovasc Med 17:19–25
Wright JW, Jensen LL, Cushing LL, Harding JW (1989) Leucine aminopeptidase M-induced reductions in blood pressure in spontaneously hypertensive rats. Hypertension 13:910–915
Wright JW, Mizutani S, Murray CE, Amir HZ, Harding JW (1990) Aminopeptidase-induced elevations and reductions in blood pressure in the spontaneously hypertensive rat. J Hypertens 8:969–974
Wright JW, Amir HZ, Murray CE, Roberts KA, Harding JW, Mizutani S, Ward PE (1991) Use of aminopeptidase M as a hypotensive agent in spontaneously hypertensive rats. Brain Res Bull 27:545–551
Reaux A, Fournie-Zaluski MC, David C, Zini S, Roques BP, Corvol P, Llorens-Cortes C (1999) Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci U S A 96:13415–13420
Zini S, Fournie-Zaluski MC, Chauvel E, Roques BP, Corvol P, Llorens-Cortes C (1996) Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci U S A 93:11968–11973
Kotlo K, Hughes DE, Herrera VL, Ruiz-Opazo N, Costa RH, Robey RB, Danziger RS (2007) Functional polymorphism of the Anpep gene increases promoter activity in the Dahl salt-resistant rat. Hypertension 49:467–472
Turner AJ (1998) Membrne alanyl aminopeptidase. In: Barret A, Rawlings ND, Woessner JF (eds) Handbook of proteolytic enzymes. Academic Press Inc., San Diego, pp. 994–1032
Goto Y, Hattori A, Ishii Y, Mizutani S, Tsujimoto M (2006) Enzymatic properties of human aminopeptidase A: Regulation of its enzymatic activity by calcium and angiotensin IV. J Biol Chem 281:23503–23513
Lalu K, Lampelo S, Vanha-Perttula T (1986) Characterization of three aminopeptidases purified from maternal serum, Biochim. Biophys Acta 873:190–197
Ofner D, Hooper NM (2002) The C-terminal domain, but not the interchain disulphide, is required for the activity and intracellular trafficking of aminopeptidase A. Biochem. J 362:191–197
Rozenfeld R, Muller L, El Messari S, Llorens-Cortes C (2004) The C-terminal domain of aminopeptidase A is an intramolecular chaperone required for the correct folding, cell surface expression, and activity of this monozinc aminopeptidase. J Biol Chem 279:43285–43295
Danielsen EM, Noren O, Sjostrom H, Ingram J, Kenny AJ (1980) Proteins of the kidney microvillar membrane: Aspartate aminopeptidase: purification by immunoadsorbent chromatography and properties of the detergent- and proteinase-solubilized forms. Biochem. J 189:591–603
Wang J, Cooper MD (1993) Histidine residue in the zinc-binding motif of aminopeptidase A is critical for enzymatic activity. Proc. Natl Acad Sci U S A 90:1222–1226
Vazeux G, Wang J, Corvol P, Llorens-Cortes C (1996) Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A. J Biol Chem 271:9069–9074
Vazeux G, Iturrioz X, Corvol P, Llorens-Cortes C (1998) A glutamate residue contributes to the exopeptidase specificity in aminopeptidase A. Biochem. J 334:407–413
Iturrioz X, Rozenfeld R, Michaud A, Corvol P, Llorens-Cortes C (2001) Study of asparagine 353 in aminopeptidase A: characterization of a novel motif (GXMEN) implicated in exopeptidase specificity of monozinc aminopeptidases. Biochemistry 40:14440–14448
Vazeux G, Iturrioz X, Corvol P, Llorens-Cortes C (1997) A tyrosine residue essential for catalytic activity in aminopeptidase A. Biochem J 327:883–889
Luciani N, Marie-Claire C, Ruffet E, Beaumont A, Roques BP, Fournie-Zaluski MC (1998) Characterization of Glu350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC 3.4.11.2): insights into its mechanism of action. Biochemistry 37:686–692
Rozenfeld R, Iturrioz X, Maigret B, Llorens-Cortes C (2002) Contribution of molecular modeling and site-directed mutagenesis to the identification of two structural residues, Arg-220 and Asp-227, in aminopeptidase A. J Biol Chem 277:29242–29252
Rozenfeld R, Iturrioz X, Okada M, Maigret B, Llorens-Cortes C (2003) Contribution of molecular modeling and site-directed mutagenesis to the identification of a new residue, glutamate 215 involved in the exopeptidase specificity of aminopeptidase A Biochemistry 42:14785–14793
Iturrioz X, Vazeux G, Celerier J, Corvol P, Llorens-Cortes C (2000) Histidine 450 plays a critical role in catalysis and, with Ca2+ contributes to the substrate specificity of aminopeptidase A Biochemistry 39:3061–3068
Goto Y, Hattori A, Mizutani S, Tsujimoto M (2007) Asparatic acid-221 is critical in the calcium-induced modulation of the enzymatic activity of human aminopeptidase A. J Biol Chem (in press)
Yamahara N, Nomura S, Suzuki T, Itakura A, Ito M, Okamoto T, Tsujimoto M, Nakazato H, Mizutani S (2000) Placental leucine aminopeptidase/oxytocinase in maternal serum and placenta during normal pregnancy. Life Sci 66:1401–1410
Kozaki H, Itakura A, Okamura M, Ohno Y, Wakai K, Mizutani S (2001) Maternal serum placental leucine aminopeptidase (P-LAP)/oxytocinase and preterm delivery. Int J Gynaecol Obstet 73:207–213
Nomura S, Ito T, Yamamoto E, Sumigama S, Iwase A, Okada M, Shibata K, Ando H, Ino K, Kikkawa F, Mizutani S (2005) Gene regulation and physiological function of placental leucine aminopeptidase/oxytocinase during pregnancy. Biochim Biophys Acta 1751:19–25
Johnson MP, Fitzpatrick E, Dyer TD, Jowett JB, Brennecke SP, Blangero J, Moses EK (2007) Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach. Mol Hum Reprod 13:61–67
Rogi T, Tsujimoto M, Nakazato H, Mizutani S, Tomoda Y (1996) Human placental leucine aminopeptidase/oxytocinase: A new member of type II membrane-spanning zinc metallopeptidase family. J Biol Chem 271:56–61
Matsumoto H, Rogi T, Yamashiro K, Kodama S, Tsuruoka N, Hattori A, Takio K, Mizutani S, Tsujimoto M (2000) Characterization of a recombinant soluble form of human placental leucine aminopeptidase/oxytocinase expressed in Chinese hamster ovary cells. Eur J Biochem 267:46–52
Ito N, Nomura S, Iwase A, Ito T, Kikkawa F, Tsujimoto M, Ishiura S, Mizutani S (2004) ADAMs, a disintegrin and metalloproteinases, mediate shedding of oxytocinase. Biochem Biophys Res Commun 314:1008–1013
Laustsen PG, Vang S, Kristensen T (2001) Mutational analysis of the active site of human insulin-regulated aminopeptidase. Eur J Biochem 268:98–104
Ye S, Chai SY, Lew RA, Albiston AL (2007) Insulin-regulated aminopeptidase: analysis of peptide substrate and inhibitor binding to the catalytic domain. Biol Chem 388:399–403
Tsujimoto M, Hattori A (2005) The oxytocinase subfamily of M1 aminopeptidases. Biochim Biophys Acta 1751:9–18
Peck GR, Ye S, Pham V, Fernando RN, Macaulay SL, Chai SY, Albiston AL (2006) Interaction of the Akt substrate, AS160, with the glucose transporter 4 vesicle marker protein, insulin-regulated aminopeptidase. Mol Endocrinol 20:2576–2583
Hosaka T, Brooks CC, Presman E, Kim SK, Zhang Z, Breen M, Gross DN, Sztul E, Pilch PF (2005) p115 interacts with the GLUT4 vesicle protein, IRAP, and plays a critical role in insulin-stimulated GLUT4 translocation. Mol Biol Cell 16:2882–2890
Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P, Baron AD (1998) Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 101:2377–2386
Masuda S, Hattori A, Matsumoto H, Miyazawa S, Natori Y, Mizutani S, Tsujimoto M (2003) Involvement of the V2 receptor in vasopressin-stimulated translocation of placental leucine aminopeptidase/oxytocinase in renal cells. Eur J Biochem 270:1988–1994
Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FA, Simpson RJ, Connolly LM, Chai SY (2001) Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 276:48623–48626
Lew RA, Mustafa T, Ye S, McDowall S, Chai SY, Albiston L A (2003) Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). J Neurochem 86:344–350
Stragier B, Demaegdt H, De Bundel D, Smolders I, Sarre S, Vauquelin G, Ebinger G, Michotte Y, Vanderheyden P (2007) Involvement of insulin-regulated aminopeptidase and/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat. Brain Res 1131:97–105
Stragier B, Clinckers R, Meurs A, De Bundel D, Sarre S, Ebinger G, Michotte Y, Smolders I (2006) Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats. J Neurochem 98:1100–1113
Matsumoto H, Nagasaka T, Hattori A, Rogi T, Tsuruoka N, Mizutani S, Tsujimoto M (2001) Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides. Eur J Biochem 268:3259–3266
Fruitier-Arnaudin I, Cohen M, Bordenave S, Sannier F, Piot JM (2002) Comparative effects of angiotensin IV and two hemorphins on angiotensin-converting enzyme activity. Peptides 23:1465–1470
Maruyama M, Hattori A, Goto Y, Ueda M, Maeda M, Fujiwara H, Tsujimoto M (2007) Laeverin/aminopeptidase Q: a novel bestatin sensitive leucine aminopeptidase belonging to the M1 family of aminopeptidases. J Biol Chem 282:20088–20096
Hattori A, Matsumoto H, Mizutani S, Tsujimoto M (1999) Molecular cloning of adipocyte-derived leucine aminopeptidase highly related to placental leucine aminopeptidase/oxytocinase. J Biochem (Tokyo) 125:931–938
Hattori A, Kitatani K, Matsumoto H, Miyazawa S, Rogi T, Tsuruoka N, Mizutani S, Natori Y, Tsujimoto M (2000) Characterization of recombinant human adipocyte-derived leucine aminopeptidase expressed in Chinese hamster ovary cells. J Biochem (Tokyo) 128:755–762
Saric T, Chang SC, Hattori A, York IA, Markant S, Rock KL, Tsujimoto M, Goldberg AL (2002) An IFN-γ-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol 3:1169–1176
Chang SC, Momburg F, Bhutani N, Goldberg AL (2005) The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a “molecular ruler” mechanism. Proc Natl Acad Sci U S A 102:17107–17012
Yamamoto N, Nakayama J, Yamakawa-Kobayashi K, Hamaguchi H, Miyazaki R, Arinami T (2002) Identification of 33 polymorphisms in the adipocyte-derived leucine aminopeptidase (ALAP) gene and possible association with hypertension. Hum Mutat 19:251–257
Hallberg P, Lind L, Michaelsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nystrom F, Liljedahl U, Syvanen AC, Melhus H (2003) Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy. BMC Cardiovasc Disord 3:11. http://www.biomedcentral.com/1471–2261/3/11
Goto Y, Hattori A, Ishii Y, Tsujimoto M (2006) Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1. FEBS Lett 580:1833–1838
Miyashita H, Yamazaki T, Akada T, Niizeki O, Ogawa M, Nishikawa S, Sato Y (2002) A mouse orthologue of puromycin-insensitive leucyl-specific aminopeptidase is expressed in endothelial cells and plays an important role in angiogenesis. Blood 99:3241–3249
Cui X, Hawari F, Alsaaty S, Lawrence M, Combs CA, Geng W, Rouhani FN, Miskinis D, Levine SJ (2002) Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest 110:515–526
Yamazaki T, Akada T, Niizeki O, Suzuki T, Miyashita H, Sato Y (2004) Puromycin-insensitive leucyl-specific aminopeptidase (PILSAP) binds and catalyzes PDK1, allowing VEGF-stimulated activation of S6K for endothelial cell proliferation and angiogenesis Blood 104:2345–2352
Islam A, Adamik B, Hawari FI, Ma G, Rouhani FN, Zhang J, Levine SJ (2006) Extracellular TNFR1 release requires the calcium-dependent formation of a nucleobindin 2-ARTS-1 complex. J Biol Chem 281:6860–6873
Tanioka T, Hattori A, Masuda S, Nomura Y, Nakayama H, Mizutani S, Tsujimoto M (2003) Human leukocyte-derived arginine aminopeptidase; The third member of the oxytocinase subfamily of aminopeptidases. J Biol Chem 278:32275–32283
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsujimoto, M., Goto, Y., Maruyama, M. et al. Biochemical and enzymatic properties of the M1 family of aminopeptidases involved in the regulation of blood pressure. Heart Fail Rev 13, 285–291 (2008). https://doi.org/10.1007/s10741-007-9064-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10741-007-9064-8